Delivery Order SPE2DB22D2007-SPE2DB25FJ3TU
- Not listed
- The Defense Logistics Agency awarded a $11,054.82 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for 500 tablets of Ondansetron HCl 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. Performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 4,...
- The Defense Logistics Agency awarded a $6,219.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Ondansetron HCL 4 mg tablets, an anti-nausea medication commonly used in military and veteran healthcare settings. The contract was competitively awarded without set-aside restrictions and is scheduled for completion by July 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This...
- The Defense Logistics Agency awarded a $43,196.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCl 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. This non-set-aside contract, awarded on September 17, 2025, is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, a commonly used anti-nausea medication. This firm fixed-price delivery order, valued at $8,642.13, was competitively awarded without set-aside provisions and is scheduled for completion by August 22, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency awarded a $9,278.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Ondansetron HCL 4 mg, an antiemetic medication commonly used in military and veteran healthcare settings. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,836.91 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and federal healthcare settings. This firm fixed-price delivery order, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's Corporate Office location...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,497.07 for 500 tablets of Ondansetron HCL 4 mg, with an ultimate completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $64,621.77 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) on September 26, 2025, with completion expected by September 29, 2025. This contract employs firm fixed-price pricing under a non-competitive, non-set-aside arrangement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,203.56 for 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and federal healthcare settings. Awarded on July 27, 2025, with an ultimate completion date of July 28, 2025, this firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of 500 tablets of Ondansetron HCL 4 mg at a ceiling value of $10,310.45. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 23, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued under the company's larger...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3TUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $29,391.06 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements, ranging from specialty medications and brand-name drugs to generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. This delivery order represents one of numerous competitively awarded transactions executed under the company's DLA framework, reflecting AmerisourceBergen's established performance in supplying time-sensitive medical commodities to support military and veteran care operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.4k | 8/7/25 |